Apollo, KKR seal €3bn Bayer reversible contraceptives deal; Aurelius agrees $323m Hain unit carve-out
Wednesday, September 16, 2026 · first reported by AltAssets
Apollo-managed funds and KKR completed €3bn (≈$3.3bn) co-investment in Bayer's long-acting reversible contraceptives business; Bayer retains majority stake and operational control.
- Firm
- Apollo
- Deal value
- $3.3B
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Apollo
Everything on this firm →More in Deals
From the same day- EQT and Norges team up in bid for Acciona EnergiaPrivate Equity Wire
- Brookfield agrees $2.8bn deal to take Reliance Worldwide privatePE Hub +1
- EU OKs £1.3B Tinicum-Blackstone Aerospace Parts DealLaw360
- Ares, PSP team up to invest $2.4bn in US logisticsPERE
- Crane Buys into Municipal Water with Trillium’s US Pump BrandsPrivate Equity Professional
- Vitruvian Partners acquires majority stake in Smartling from Battery VenturesPE Hub